Seasonal influenza continues to represent a major health challenge worldwide, increasingly complicated by the virus’s evolving resistance to available treatments. To help address this issue, the Influenza Antiviral Drug Search initiative, conducted by the University of Texas Medical Branch and supported by the World Community Grid via BOINC, relies on the combined computing power of thousands of volunteers around the globe. This distributed framework enables large-scale virtual screening of potential antiviral molecules directed at essential influenza proteins, including neuraminidase, hemagglutinin, and NS1. Through the integration of bioinformatics and molecular modeling, the project demonstrates how collective computing can accelerate the early discovery of antiviral candidates and pave the way toward smarter, AI-assisted drug design in the future. The results illustrate the growing relevance of open, collaborative computing infrastructures in the next generation of biomedical research.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Accelerating Influenza Antiviral Discovery with BOINC Computing

  • Fadwa Bouyaakoubi,
  • Lahcen Tamym,
  • Lyes Benyoucef,
  • Ahmed Nait Sidi Moh,
  • Moulay Driss El Ouadghiri

摘要

Seasonal influenza continues to represent a major health challenge worldwide, increasingly complicated by the virus’s evolving resistance to available treatments. To help address this issue, the Influenza Antiviral Drug Search initiative, conducted by the University of Texas Medical Branch and supported by the World Community Grid via BOINC, relies on the combined computing power of thousands of volunteers around the globe. This distributed framework enables large-scale virtual screening of potential antiviral molecules directed at essential influenza proteins, including neuraminidase, hemagglutinin, and NS1. Through the integration of bioinformatics and molecular modeling, the project demonstrates how collective computing can accelerate the early discovery of antiviral candidates and pave the way toward smarter, AI-assisted drug design in the future. The results illustrate the growing relevance of open, collaborative computing infrastructures in the next generation of biomedical research.